NRSN

NeuroSense Therapeutics Ltd.

Nasdaq · Pharmaceutical Preparations · Inc. L3 · CIK 0001875091
$0.7520 +0.27% $26.6M
Vol
Market Cap$26.6M
Cap SizeNano Cap
Analyst ConsensusStrong Buy (89%)
Exchange Nasdaq·Sector Pharmaceutical Preparations·Inc. L3·CIK 0001875091·Prev Close $0.7500

Recent Activity

Mar 26, 2026 Insider
Eisenberg Or sold 200,000 shares
Chief Financial Officer @ $0.00 ($0.00)
Mar 26, 2026 Insider
Binder Hagit sold 200,000 shares
General Manager @ $0.00 ($0.00)
Mar 26, 2026 Insider
Russek-Blum Niva sold 200,000 shares
Chief Technology Officer @ $0.00 ($0.00)
Mar 25, 2026 earnings_calendar
NRSN Q4 2025 Earnings Before Market Open — 2026-03-25

Price Targets

$6.50 +755.3% upside Strong Buy
Current $0.7600 Low $3.00 Median $7.50 High $9.00 3 analysts
$3.00 $9.00

Analyst Ratings

Strong Buy89% buy · 9 analysts
2Strong Buy
6Buy
1Hold
0Sell
0Strong Sell
Recent Analyst Actions
DateFirmActionRating
Apr 8, 2026 D. Boral Capital MAINTAIN Buy → Buy
Mar 25, 2026 D. Boral Capital MAINTAIN Buy → Buy
Mar 17, 2026 D. Boral Capital MAINTAIN Buy → Buy
Mar 10, 2026 Roth Capital INITIATE Buy
Mar 9, 2026 D. Boral Capital MAINTAIN Buy → Buy

Earnings Estimates

PeriodEPS Est.RangeGrowth#
Current FY $-0.40 ▼ -31.1% $-0.40 — $-0.40 9% YoY 1
Next FY $-0.82 ▼ -62.4% $-0.82 — $-0.82 -105% YoY 1

Recent Insider Trades

DateInsiderTypeValue
Mar 26, 2026Eisenberg OrA$0.00
Mar 26, 2026Binder HagitA$0.00
Mar 26, 2026Russek-Blum NivaA$0.00

No institutional holding data available yet. Data is sourced from 13F filings which are filed quarterly.

3 unique insiders with 0 transactions. Net insider value: $0.00 ($0.00 bought, $0.00 sold).

Insider Transactions

DateInsiderTitleTypeSharesPriceValue
Mar 26, 2026Eisenberg OrChief Financial OfficerA200,000$0.00$0.00
Mar 26, 2026Binder HagitGeneral ManagerA200,000$0.00$0.00
Mar 26, 2026Russek-Blum NivaChief Technology OfficerA200,000$0.00$0.00

No SEC filing reports analyzed yet. Reports are generated when new filings are detected and processed by the LLM pipeline.

No press releases analyzed yet. Press releases are collected from GlobeNewsWire and analyzed by the LLM pipeline.

Current analyst consensus: Strong Buy (89% buy). Based on 9 analysts: 2 strong buy, 6 buy, 1 hold, 0 sell, 0 strong sell.

Analyst Price Targets

$6.50 mean target +755.3% upside Strong Buy (3.00)
$3.00 Low $9.00 High
MetricValue
Current Price$0.7600
Target Low$3.00
Target Mean$6.50
Target Median$7.50
Target High$9.00
# Analysts3
RecommendationStrong Buy (3.00)

Earnings Estimates & Revisions

PeriodEPS AvgEPS LowEPS HighEPS Growth30d Rev.Up/DownRev. AvgRev. GrowthAnalysts
Current Q
2026-03-31
$0.00 $0.00 $0.00 $0.0B
Next Q
$0.00 $0.00 $0.00 $0.0B
Current FY
2026-12-31
$-0.40 $-0.40 $-0.40 9.1% -31.1% $0.0B 0.0% 1
Next FY
2027-12-31
$-0.82 $-0.82 $-0.82 -105.0% -62.4% $0.0B 0.0% 1
2 analyst firms have rated this stock: 0 upgrades, 0 downgrades, 1 initiations.

Individual Analyst Actions

DateAnalyst FirmActionPrevious RatingNew Rating
Apr 8, 2026 D. Boral Capital MAINTAIN Buy Buy
Mar 25, 2026 D. Boral Capital MAINTAIN Buy Buy
Mar 17, 2026 D. Boral Capital MAINTAIN Buy Buy
Mar 10, 2026 Roth Capital INITIATE Buy
Mar 9, 2026 D. Boral Capital MAINTAIN Buy Buy
Dec 22, 2025 D. Boral Capital MAINTAIN Buy Buy

Monthly Consensus History

PeriodStrong BuyBuyHoldSellStrong SellBuy %Distribution
Jun 1, 20262610089%
May 1, 20262710090%
Apr 1, 20262710090%
Mar 1, 20262610089%
Feb 1, 20262620080%
Jan 1, 20262620080%
Strong BuyBuyHoldSellStrong Sell

No congressional trading data available for this ticker. Data is sourced from Senate and House financial disclosure filings.

No Reddit sentiment data available yet. Sentiment is analyzed from Reddit investment communities on a rolling basis.

Mar 25, 2026
earnings_calendar
NRSN Q4 2025 Earnings Before Market Open — 2026-03-25
Feb 20, 2026
earnings_calendar
NRSN Q3 2025 Earnings Scheduled — 2026-02-20